Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Rabies in the 21 century.

Wunner WH, Briggs DJ.

PLoS Negl Trop Dis. 2010 Mar 30;4(3):e591. doi: 10.1371/journal.pntd.0000591. Review. No abstract available.

2.

Rabies in the Americas.

Wunner WH.

Virus Res. 2005 Jul;111(1):1-4. Epub 2005 Apr 9. No abstract available.

PMID:
15896397
3.

N-glycosylation at one rabies virus glycoprotein sequon influences N-glycan processing at a distant sequon on the same molecule.

Wojczyk BS, Takahashi N, Levy MT, Andrews DW, Abrams WR, Wunner WH, Spitalnik SL.

Glycobiology. 2005 Jun;15(6):655-66. Epub 2005 Jan 26.

PMID:
15677380
4.

Selection of genetic inhibitors of rabies virus.

Wunner WH, Pallatroni C, Curtis PJ.

Arch Virol. 2004 Aug;149(8):1653-62. Epub 2004 Apr 15.

PMID:
15290388
5.

Management of rabies in humans.

Jackson AC, Warrell MJ, Rupprecht CE, Ertl HC, Dietzschold B, O'Reilly M, Leach RP, Fu ZF, Wunner WH, Bleck TP, Wilde H.

Clin Infect Dis. 2003 Jan 1;36(1):60-3. Epub 2002 Dec 11.

PMID:
12491203
6.

Basis of rabies virus neurovirulence in mice: expression of major histocompatibility complex class I and class II mRNAs.

Irwin DJ, Wunner WH, Ertl HC, Jackson AC.

J Neurovirol. 1999 Oct;5(5):485-94.

PMID:
10568885
7.

The specificity of rabies virus RNA encapsidation by nucleoprotein.

Yang J, Hooper DC, Wunner WH, Koprowski H, Dietzschold B, Fu ZF.

Virology. 1998 Mar 1;242(1):107-17.

8.

The role of site-specific N-glycosylation in secretion of soluble forms of rabies virus glycoprotein.

Wojczyk BS, Stwora-Wojczyk M, Shakin-Eshleman S, Wunner WH, Spitalnik SL.

Glycobiology. 1998 Feb;8(2):121-30.

PMID:
9451021
9.

Expression of an antigen homologous to the human CO17-1A/GA733 colon cancer antigen in animal tissues.

Zaloudik J, Basak S, Nesbit M, Speicher DW, Wunner WH, Miller E, Ernst-Grotkowski C, Kennedy R, Bergsagel LP, Koido T, Herlyn D.

Br J Cancer. 1997;76(7):909-16.

10.

Purification of a secreted form of recombinant rabies virus glycoprotein: comparison of two affinity tags.

Wojczyk BS, Czerwinski M, Stwora-Wojczyk MM, Siegel DL, Abrams WR, Wunner WH, Spitalnik SL.

Protein Expr Purif. 1996 Mar;7(2):183-93.

PMID:
8812859
11.

HPLC purification of synthetic oligodeoxyribonucleotides containing base- and backbone-modified sequences.

Green AP, Burzynski J, Helveston NM, Prior GM, Wunner WH, Thompson JA.

Biotechniques. 1995 Nov;19(5):836-41.

PMID:
8588925
12.
13.

Stable secretion of a soluble, oligomeric form of rabies virus glycoprotein: influence of N-glycan processing on secretion.

Wojczyk B, Shakin-Eshleman SH, Doms RW, Xiang ZQ, Ertl HC, Wunner WH, Spitalnik SL.

Biochemistry. 1995 Feb 28;34(8):2599-609.

PMID:
7873541
14.

Characterization of protein involvement in rabies virus binding to BHK-21 cells.

Broughan JH, Wunner WH.

Arch Virol. 1995;140(1):75-93. Erratum in: Arch Virol 1995;140(7):1343.

PMID:
7646349
15.

Both the N- and the C-terminal domains of the nominal phosphoprotein of rabies virus are involved in binding to the nucleoprotein.

Fu ZF, Zheng Y, Wunner WH, Koprowski H, Dietzschold B.

Virology. 1994 May 1;200(2):590-7.

PMID:
8178445
16.

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC.

Virology. 1994 Feb 15;199(1):132-40.

PMID:
8116236
17.

Immunoprotection by rabies virus nucleoprotein.

Fu ZF, Wunner WH, Dietzschold B.

Curr Top Microbiol Immunol. 1994;187:161-72. Review. No abstract available.

PMID:
7532122
18.
19.

Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein.

Fu ZF, Rupprecht CE, Dietzschold B, Saikumar P, Niu HS, Babka I, Wunner WH, Koprowski H.

Vaccine. 1993;11(9):925-8.

PMID:
8212838
20.

N-linked glycosylation of rabies virus glycoprotein. Individual sequons differ in their glycosylation efficiencies and influence on cell surface expression.

Shakin-Eshleman SH, Remaley AT, Eshleman JR, Wunner WH, Spitalnik SL.

J Biol Chem. 1992 May 25;267(15):10690-8.

21.

Immune response to the nominal phosphoprotein of rabies virus.

Larson JK, Wunner WH, Ertl HC.

Virus Res. 1992 Apr;23(1-2):73-88.

PMID:
1534957
22.

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. 1984.

Wiktor TJ, MacFarlan RI, Reagan KJ, Dietzschold B, Curtis PJ, Wunner WH, Kieny MP, Lathe R, Lecocq JP, Mackett M, et al.

Biotechnology. 1992;24:508-12. No abstract available.

PMID:
1422063
24.
25.

Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine.

Fu ZF, Dietzschold B, Schumacher CL, Wunner WH, Ertl HC, Koprowski H.

Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):2001-5.

26.

Stable expression of rabies virus glycoprotein in Chinese hamster ovary cells.

Burger SR, Remaley AT, Danley JM, Moore J, Muschel RJ, Wunner WH, Spitalnik SL.

J Gen Virol. 1991 Feb;72 ( Pt 2):359-67.

PMID:
1993876
27.
28.

Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.

Dietzschold B, Gore M, Marchadier D, Niu HS, Bunschoten HM, Otvos L Jr, Wunner WH, Ertl HC, Osterhaus AD, Koprowski H.

J Virol. 1990 Aug;64(8):3804-9.

30.
31.

Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein.

Ertl HC, Dietzschold B, Gore M, Otvos L Jr, Larson JK, Wunner WH, Koprowski H.

J Virol. 1989 Jul;63(7):2885-92.

32.

Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein.

Bunschoten H, Gore M, Claassen IJ, Uytdehaag FG, Dietzschold B, Wunner WH, Osterhaus AD.

J Gen Virol. 1989 Feb;70 ( Pt 2):291-8.

PMID:
2471786
33.

The molecular biology of rabies viruses.

Wunner WH, Larson JK, Dietzschold B, Smith CL.

Rev Infect Dis. 1988 Nov-Dec;10 Suppl 4:S771-84. Review.

PMID:
2462742
34.

Genetic restriction and fine specificity of human T cell clones reactive with rabies virus.

Celis E, Karr RW, Dietzschold B, Wunner WH, Koprowski H.

J Immunol. 1988 Oct 15;141(8):2721-8.

PMID:
2459225
35.

Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies.

Dietzschold B, Tollis M, Lafon M, Wunner WH, Koprowski H.

Virology. 1987 Nov;161(1):29-36.

PMID:
3672933
36.

Localization and immunological characterization of antigenic domains of the rabies virus internal N and NS proteins.

Dietzschold B, Lafon M, Wang H, Otvos L Jr, Celis E, Wunner WH, Koprowski H.

Virus Res. 1987 Aug;8(2):103-25.

PMID:
2445121
37.

Rabies virus infection: genetic mutations and the impact on viral pathogenicity and immunity.

Wunner WH, Dietzschold B.

Contrib Microbiol Immunol. 1987;8:103-24. Review. No abstract available.

PMID:
3304828
38.

Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine.

Rupprecht CE, Wiktor TJ, Johnston DH, Hamir AN, Dietzschold B, Wunner WH, Glickman LT, Koprowski H.

Proc Natl Acad Sci U S A. 1986 Oct;83(20):7947-50.

39.

Cloning of rabies virus matrix protein mRNA and determination of its amino acid sequence.

Rayssiguier C, Cioe L, Withers E, Wunner WH, Curtis PJ.

Virus Res. 1986 Aug;5(2-3):177-90.

PMID:
3765822
40.
41.

Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro.

Dietzschold B, Wiktor TJ, Trojanowski JQ, Macfarlan RI, Wunner WH, Torres-Anjel MJ, Koprowski H.

J Virol. 1985 Oct;56(1):12-8.

42.

Antigenic variants of CVS rabies virus with altered glycosylation sites.

Wunner WH, Dietzschold B, Smith CL, Lafon M, Golub E.

Virology. 1985 Jan 15;140(1):1-12.

PMID:
3966297
43.
44.

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.

Wiktor TJ, Macfarlan RI, Reagan KJ, Dietzschold B, Curtis PJ, Wunner WH, Kieny MP, Lathe R, Lecocq JP, Mackett M, et al.

Proc Natl Acad Sci U S A. 1984 Nov;81(22):7194-8.

45.

Characterization of saturable binding sites for rabies virus.

Wunner WH, Reagan KJ, Koprowski H.

J Virol. 1984 Jun;50(3):691-7.

46.

Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies.

Lafon M, Ideler J, Wunner WH.

Dev Biol Stand. 1984;57:219-25.

PMID:
6084612
47.

Anti-idiotypic antibodies induce neutralizing antibodies to rabies virus glycoprotein.

Reagan KJ, Wunner WH, Wiktor TJ, Koprowski H.

J Virol. 1983 Dec;48(3):660-6.

48.

Rabies subunit vaccines.

Wunner WH, Dietzschold B, Curtis PJ, Wiktor TJ.

J Gen Virol. 1983 Aug;64 (Pt 8):1649-56. Review. No abstract available.

PMID:
6348210
49.

Chemical and immunological analysis of the rabies soluble glycoprotein.

Dietzschold B, Wiktor TJ, Wunner WH, Varrichio A.

Virology. 1983 Jan 30;124(2):330-7.

PMID:
6823748
50.

Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.

Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H.

Proc Natl Acad Sci U S A. 1983 Jan;80(1):70-4.

Supplemental Content

Loading ...
Support Center